Skip to content
Home
About
About Us
R&D Team
Quality System
Honors & Certifications
Patent & Technology
R&D
Stem Cell
Exosome
Immune Cell
Genetic engineering+
Industrialization Center
Drug Pipeline
Clinical Translation
Research Services
Social Responsibility
Public Welfare
Green Production
Media Center
Company News
Video Center
Join Us
Cooperations
Investor Relations
Supplier Relationships
Join us
简体中文
Navigation Menu
Navigation Menu
Home
About
About Us
R&D Team
Quality System
Honors & Certifications
Patent & Technology
R&D
Stem Cell
Exosome
Immune Cell
Genetic engineering+
Industrialization Center
Drug Pipeline
Clinical Translation
Research Services
Social Responsibility
Public Welfare
Green Production
Media Center
Company News
Video Center
Join Us
Cooperations
Investor Relations
Supplier Relationships
Join us
简体中文
Media Center
Leading the development of cell biotechnology and benefiting human health!
首页
/
公司动态
/
新闻|茵冠生物最新款干细胞新药IND获受理!
新闻|茵冠生物最新款干细胞新药IND获受理!
2026年06月18日
51
← 上一篇